Showing posts with label clinical and experimental ophthalmology submission. Show all posts
Showing posts with label clinical and experimental ophthalmology submission. Show all posts

Tuesday, 18 April 2017

Combined Antifungal therapy is effective in handling fungal keratitis

Fungal keratitis is an alarming disease with a significant impact on the vision quality. Although anti fungal drugs are effective in controlling this disorder, a significant challenge lies in the management of the disease. 

clinical and experimental ophthalmology submission
The drug delivery into the corneal tissues and identification of fungal pathogens play important roles in management of fungal keratitis. Although 10 different varieties of antibacterial, antifungal and cycloplegic drugs are available, a combined therapy of antifungal agents achieved the best treatment modality in cases of fungal keratitis.

Monday, 3 April 2017

Saints and Ophthalmology: A Pattern for Emulation, a Model of Healing, and Physicians in Action

From the earliest times, medical practitioners have sought divine help and support to aid them as they go about their busy rounds. In Christian Europe of the High Middle Ages, saints played a central role in the everyday life of the ailing. Alongside healing attempts which involved magic, folk or scientifically-based medicine, the invocation of specific patron saints for the curing of ailments was a widespread practice. 

clinical and experimental ophthalmology impact factor
The miracles of vision performed by saints over the past two millennia are listed and interpreted by various reviewers along faith healing, spontaneous recovery, or physicians acting as saints. The individuals honored as patron saints of medicine were practicing physicians who served their patients and their communities well. It is their role as saints to represent the spiritual element in the healing process as well as personifying the charitable idealism of the good physician, and therefore are models for humanitarian physicians, with the ultimate model of healing being Jesus Christ.

Tuesday, 21 March 2017

The Disease Course of Bilateral Endogenous Fungal Endophthalmitis

To report the dynamic disease course of a case of bilateral endogenous fungal endophthalmitis, which was successfully treated? Case Report: A 54 year old Chinese man with a history ofextracorporeal shock wave lithotripsy (ESWL) and ureteroscopy was referred to our center. After 1 week, his best corrected Snellen visual acuity (BCVA) values were 20/100 and 20/25; the interface between the posterior vitreous face and the retinal surface appeared to be rough in the right eye, and a similar, larger, low-rounded circumscribed apophysis could be observed in the left eye.

clinical experimental ophthalmology journal
During the 2nd week, his BCVA values decreased to 20/400 and 20/32. He was diagnosed with bilateral endogenous Candida albicans endophthalmitis after a vitreous biopsy and then underwent binocular pars plana vitrectomy (PPV) with silicone oil injection in both eyes. Post operatively, his BCVA values were 20/63 and 20/32, and fundoscopy and optical coherence tomography (OCT) showed a regular and smooth interface and retina surface after the removal of the silicone oil at 3 months.